Buprenorphine vs Tofacitinib

## Buprenorphine vs Tofacitinib: Overview

This comparison examines the pharmacological differences between **Buprenorphine** and **Tofacitinib**.

## Mechanism of Action

**Buprenorphine**: Partial mu-opioid receptor agonist and kappa antagonist with high receptor affinity.

**Tofacitinib**: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.

## Pharmacokinetics

**Half-life**: Buprenorphine — 24-42 hours; Tofacitinib — 3.2 hours.

## Chemical Properties

**Molecular Formula**: Buprenorphine — C29H41NO4; Tofacitinib — C16H20N6O.

**Molecular Weight**: Buprenorphine — 467.6430 g/mol; Tofacitinib — 312.3700 g/mol.

**Type**: Buprenorphine — Small molecule; Tofacitinib — Small molecule.